RxDoctor Payments DataLook up a doctor →

Anthony Rees

Family · Weirton, WVNPI 1104312206

Payments from drug & device makers

$7,430in general payments, 2019–2025

Across 481 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$1K
  • AstraZeneca$759
  • Lilly USA, LLC$462
  • Pfizer$412
  • Daiichi Sankyo Inc.$319
  • plus $3K from 39 others

What the payments were for

  • Food & beverage$7,430100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,430 in reported general payments places this provider in the 95th percentile of 1,507 family providers in West Virginia.

See all family providers in West Virginia

Medicare billing

Part B allowed, 2024
$24,872
Medicare patients
196
Services billed
523

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide87$119,639
Trelegy ElliptaFluticasone/Umeclidin/Vilanter84$67,146
EliquisApixaban50$37,274
FarxigaDapagliflozin Propanediol21$29,106
JardianceEmpagliflozin42$28,841
TrulicityDulaglutide29$27,413
Nurtec OdtRimegepant Sulfate18$26,508
XareltoRivaroxaban15$20,487
Soliqua 100-33Insulin Glargine/Lixisenatide13$16,135
MounjaroTirzepatide13$13,591
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$11,726
Tresiba Flextouch U-200Insulin Degludec19$10,879
JanumetSitagliptin Phos/Metformin Hcl14$10,522
LinzessLinaclotide12$6,931
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$5,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,066$119,63987 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$141$77,924115 claims
PfizerEliquis, Nurtec Odt$412$63,78268 claims
Lilly USA, LLCTrulicity, Mounjaro$462$41,00442 claims
AstraZenecaFarxiga, Breztri Aerosphere$759$40,83240 claims
Boehringer IngelheimJardiance$68$28,84142 claims
Johnson & JohnsonXarelto$193$20,48715 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$87$16,13513 claims
MerckJanumet$111$10,52214 claims
AbbVieLinzess$1,258$6,93112 claims
Almatica Pharma LLCSertraline Hcl$13$725125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,507 family providers in West Virginia.

Other family in Weirton

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →